Generation Bio Co.

NASDAQ
GBIO
Stock
Yield per half year: -74.3%
Dividend yield: 0%
Sector: Healthcare

0.3701 $

0 $ 0%
0.324 $
3.51 $

Min/max per year

Share chart Generation Bio Co.

Extended chart Simple chart
Financial Markets by TradingView

About Generation Bio Co.

Generation Bio Co., компания по производству генетических лекарств, разрабатывает генную терапию для лечения редких и распространенных заболеваний. Компания разрабатывает портфель из восьми программ для лечения редких и распространенных заболеваний печени и сетчатки. Она также фокусируется на заболеваниях скелетных мышц, центральной нервной системы и онкологии. Компания ранее была известна как Torus Therapeutics, Inc. и сменила свое название на Generation Bio Co. в ноябре 2017 года. Generation Bio Co. была основана в 2016 году со штаб-квартирой в Кембридже, штат Массачусетс.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Main settings

IPO date 2020-06-12
ISIN US37148K1007
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт link
Change price per day: 0% (0.3701)
Change price per week: -7.89% (0.4018)
Change price per month: -12.01% (0.4206)
Change price per 3 month: -38.73% (0.604)
Change price per half year: -74.3% (1.44)
Change price per year: -87.94% (3.07)
Change price per 3 year: -93.48% (5.68)
Change price per year to date: -66.35% (1.1)
All parameters

Grade

Underestimation
Title Value Grade
P/S 3.55 5
P/BV 0.8192 9
P/E 151.29 1
Efficiency
Title Value Grade
ROA, % -43.46 0
ROE, % -91.02 0
ROIC, % -27.33 0
Dividends
Title Value Grade
Dividend yield 0 0
DSI 0 0
Average dividend growth 0 0
Debt
Title Value Grade
Debt/EBITDA -1.26 10
Debt/Ratio 0.4047 10
Debt/Equity 1.68 7
Growth impulse
Title Value Grade
Yield Revenue, % 55155.56 10
Yield Ebitda, % -8.43 0
Yield EPS, % -29.67 0
More

Main owners

Institutions Volume Share, %
Atlas Venture Life Science Advisors, LLC 8 279 484 12.45
Price (T.Rowe) Associates Inc 6 926 174 10.42
FMR, LLC 5 352 399 8.05
Bellevue Group AG 3 617 080 5.44
Blackrock Inc. 3 168 415 4.77
Artal Group S.A. 2 814 191 4.23
Vanguard Group Inc 2 552 251 3.84
Bank of America Corporation 2 527 862 3.8
EcoR1 Capital, LLC 2 046 867 3.08
PFM Health Sciences, LP 1 622 487 2.44

Similar companies

P/E & P/BVEV/Ebitda & Debt/Ebitda


Company management

Head Job title Payment Year of birth
Dr. Matthew Norkunas M.B.A., M.D. Chief Financial Officer 611.11k 1978 (47 years)
Dr. Robert Kotin Ph.D. Co-Founder N/A 1956 (69 years)
Dr. Matthew Stanton Ph.D. Chief Scientific Officer 654.83k 1973 (52 years)
Dr. Mark D. Angelino Ph.D. Co-Founder N/A 1973 (52 years)
Dr. Cameron Geoffrey McDonough M.D. President, CEO & Director 939.09k 1970 (55 years)
Ms. Jasmin Tower Chief Human Resources Officer N/A
Ms. Antoinette Paone M.B.A., M.S. Chief Operating Officer N/A 1978 (47 years)
Ms. Yalonda Howze J.D. Chief Legal Officer & Secretary N/A 1972 (53 years)
Dr. Phillip Samayoa Ph.D. Chief Strategy Officer N/A 1987 (38 years)

About company

Address: United States, Cambridge, 301 Binney Street - Open in google maps, Open in yandex maps
Website: http://generationbio.com